Skip to main content

Purdue Pharma Proposes $10-12B To Settle Opioid Crisis

Purdue Pharma Proposes $10-12B To Settle Opioid Crisis

Purdue Pharma Proposes $10-12B To Settle Opioid Crisis

Introduction

Drugmaker and distributor Purdue Pharma LP and its owners, the Sackler family, have proposed $10 billion to $12 billion to settle more than 2,000 opioid lawsuits against the company.

The proposed deal was part of a confidential discussion by Purdue's lawyers at a meeting held in Cleveland on August 20. The discussion included 10 state attorneys and the plaintiff's attorneys, where David Sackler, the spokesperson for Purdue, represented the Sackler family. Purdue is among the several drugmakers that have been alleged for fueling the opioid epidemic in the United States. According to the U.S. Centers for Disease Control and Prevention, the epidemic claimed 400,000 lives between 1999 to 2017.

The Stamford, Connecticut-based Purdue Pharma is facing allegations claiming that it aggressively marketed prescription opioids by misleading prescribers and consumers about risks from its prolonged use. Purdue said it is actively working with state attorneys general and other plaintiffs to resolve the crisis, and currently, there is no agreement, and the settlement discussions could collapse.

Companies manufacturing opioids convinced the medical community that these medications were not addictive and were purely beneficial. This belief raised the number of prescriptions and sales unwarrantedly, resulting in a mass misuse of these drugs, to the extent that this was identified by the U.S. Food and Drug Administration (FDA) as a public issue and named it an 'opioid crisis.'

Opioid lawsuits are consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation) presided by Judge Dan Polster.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!